Plain-English translation of NCT07293585 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a specialized form of radiation therapy for prostate cancer that uses advanced imaging and planning techniques to focus treatment on the cancer while sparing nearby blood vessels and nerves that affect erectile function. Prostate cancer radiation therapy can sometimes damage these sensitive structures, leading to sexual dysfunction. This study compares two approaches: standard precision radiation and a newer method that actively protects these critical structures during treatment.
Many men experience erectile dysfunction after radiation therapy for prostate cancer because the treatment can damage nearby blood vessels and nerves. This trial exists to see if modern imaging and planning techniques can effectively treat the cancer while protecting these sensitive structures, potentially reducing this common side effect.
You likely qualify if…
You likely don't qualify if…
You would receive 5 radiation therapy treatments over roughly 18 days, given either every other day or on consecutive days as needed. Each treatment uses advanced imaging to guide the radiation precisely to the cancer while protecting nearby structures. Depending on which group you're assigned to, your treatment plan may be adjusted daily based on new imaging to ensure the best targeting. You will also have MRI and CT scans during screening and at other points in the study, along with blood tests to monitor your health throughout the trial.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States